Text Message Intervention for Prevention of Cardiovascular Disease in Primary Care Patients With Hypertension (PUSH-ME)
Primary Purpose
Hypertension, Cardiovascular Risk Factor
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
SMS
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Hypertension, Text Messaging, Primary Prevention, Cardiovascular Risk Factor, Primary Health Care, Health Promotion
Eligibility Criteria
Inclusion Criteria:
- Patients with hypertension (defined by the International classification of disease Manual ICD-10, diagnose code I10.9).
- 40 to 80 years of age
- Patient must own a mobile phone compatible with SMS
Exclusion Criteria:
- History of myocardial infarction, stroke, transient ischemic attack (TIA), claudicatio intermittens, abdominal aortic aneurysm, previous heart surgery i.e. PCI or bypass (reported by recruiting physician or by patient in the questionnaire)
- Blood pressure at baseline visit ≥180/110 mmHg or systolic blood pressure <120 mmHg.
- Serious illness, other than cardiovascular, with short life expectancy (<1 year)
- Predicted inability to comply with the study protocol e.g. language difficulties, interpreter needs, serious cognitive impairment.
Sites / Locations
- Lomma vårdcentral
- Löddeköpinge vårdcentral
- Sorgenfri vårdcentral
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
SMS group
Control
Arm Description
Participants in the intervention group will receive four semi-personalized messages per week in addition to their usual care according to the National Board of Health and Welfare guidelines for hypertension treatment.
The control group will receive usual care according to the National Board of Health and Welfare guidelines for hypertension treatment.
Outcomes
Primary Outcome Measures
Change in blood pressure
Measured by automated devices (mmHg)
Secondary Outcome Measures
Changes in cholesterol
Measured by blood test, total cholesterol (mmol/l)
Changes in high-density lipoprotein [HDL]
Measured by blood test, high-density lipoprotein [HDL] (mmol/l)
Changes in low-density lipoprotein [LDL]
Measured by blood test, low-density lipoprotein [LDL] (mmol/l)
Changes in tobacco use
Self-reported
Changes in BMI
Measured by research assistant at baseline and follow up (weight and hight will be combined to report BMI in kg/m2)
Changes in Blood glucose
HbA1c
Changes in self-rated health
five-graded Likert scale from excellent to poor. The question posed is; in general, would you say that you health is excellent, very good, good, fair, or poor?
Changes in self rated quality of life
EQ5D-5L (EuroQol 5 dimentions).The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.
Changes in level of physical activity
self-reported physical activity
Changes in alcohol use
self-reported
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03442257
Brief Title
Text Message Intervention for Prevention of Cardiovascular Disease in Primary Care Patients With Hypertension
Acronym
PUSH-ME
Official Title
PUSH ME (Primary Care USage of Health Promoting Messages): A Text Message-based Intervention for Prevention of Cardiovascular Disease in Primary Care Patients With Hypertension: a Randomized Controlled Pilot Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
March 19, 2018 (Actual)
Primary Completion Date
December 18, 2018 (Actual)
Study Completion Date
December 18, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lund University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary objective of the study is to examine the impact of lifestyle advices, administered through regularly sent SMS, on hypertension in a primary health care setting. The secondary objective is to evaluate changes in other cardiovascular risk factors and general health, e.g. tobacco use, obesity, blood lipids, blood glucose, self-rated health and health-related quality of life.
Detailed Description
Background- The globalization of unhealthy lifestyles and demographic ageing of the world's population has contributed to the fact that high blood pressure is classified by World Health Organization as the world's leading risk for mortality.
Persistent hypertension is a key risk factor for coronary heart disease (CHD), stroke and other cardiovascular diseases (CVD), such as heart failure. CVD is, despite a decline in recent decades, still the leading cause of death in Sweden (4). The prevalence of hypertension in adults is around 40% according to a recent multinational study (5). In 30-40% of hypertensive individuals, additional metabolic risk factors such as dyslipidemia, insulin resistance and elevated glucose occur simultaneously, which further multiply the risk for heart disease, diabetes and stroke. An unhealthy lifestyle with physical inactivity and excess energy intake is the major driver of these metabolic risk factors. In most cases lifestyle intervention can reverse or reduce the unfavorable metabolic profile.
Primary healthcare in Sweden is managing the first-line healthcare, offering both prevention and treatment for a majority of chronic diseases. In Sweden, the vast majority of patients with hypertension are treated in primary health care. If the hypertension is well controlled, the GP typically meets the patient once a year for medical checkup, blood tests and medical prescription.
Interventions by SMS-texting have been shown to significantly improve compliance to medications, follow-up rate or disease monitoring.
Trial Design - Randomised clinical trial
Intervention - The experimental treatment will consist of an SMS-intervention addressing metabolic risk factors associated with cardiovascular disorders in patients with hypertension.
After baseline measurement participants in the intervention group will receive four semi-personalized messages per week in addition to their usual care according to the National Board of Health and Welfare guidelines for hypertension treatment. The text messages will be developed to support healthy life style changes i.e. regarding general cardiovascular health, tobacco use, physical activity and diet.
Control Treatment - The control group will receive usual care according to the National Board of Health and Welfare guidelines for hypertension treatment.
Recruitment - The participants will be recruited consecutively from three different PHCCs in Skåne. Patients with hypertension will receive information about the study at their annual check-up or other appointment with their GP. If they choose to participate, they will be contacted by phone by a research assistant for additional information, possibility to ask questions about the study, and scheduling a baseline control at their PHCC.
Baseline examination - Included patients that consent to take part in the study will be invited to their PHCC for a baseline visit. The following measurements will be assessed by a research assistant: blood pressure (in sitting position after 5 minutes rest; mean of two measurements in a standardized procedure with validated electronic BP devices), BMI and waist-hip circumference. Furthermore, the patients will complete a short questionnaire for evaluation of medical history, medication, tobacco and alcohol use, physical activity level, self-rated health and health-related quality of life. Blood samples for fasting plasma glucose, HbA1c and cholesterol will be drawn in the morning within a few days after the baseline visit.
Randomization- Randomization to study groups will be performed after completion of baseline assessments and questionnaires. A computer generated random number schedule with block sizes of four will be prepared. To assure allocation concealment, the information about group affiliation will be delivered through sealed envelopes.
The research assistant, the patients' GPs, as well as all researchers except Magnus Sandberg (MS) will be blinded to group allocation. If the patients have questions regarding the SMS function they will be able to contact MS for help.
Follow up- Follow up control will be performed after 6 months with the same assessments as at the baseline visit.
Power and sample size - For the pilot study we have assumed that a total number of 60 patients (20 patients per PHCC) will be sufficient to evaluate the feasibility of the intervention and the logistics of the assessments.
For the future full scale study, each group must contain 143 participants. The sample size is based on an assumed statistical power of 80 %, a two-sided test, a significance level of 5 %, a difference of 5 mm Hg between the groups, a standard deviation of 14 mm Hg and a drop out rate of 15 %.
Analysis plan - Data will be analysed according to the Intention-to-treat principle. Differences in mean change of end points between intervention and control groups will be calculated by ANCOVA, with baseline values as covariates.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension, Cardiovascular Risk Factor
Keywords
Hypertension, Text Messaging, Primary Prevention, Cardiovascular Risk Factor, Primary Health Care, Health Promotion
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
Care ProviderInvestigatorOutcomes Assessor
Masking Description
The research assistant, the patients' GPs, as well as all researchers except one (MS) will be blinded to group allocation. If the patients have questions regarding the SMS function they will be able to contact MS for help.
Allocation
Randomized
Enrollment
59 (Actual)
8. Arms, Groups, and Interventions
Arm Title
SMS group
Arm Type
Experimental
Arm Description
Participants in the intervention group will receive four semi-personalized messages per week in addition to their usual care according to the National Board of Health and Welfare guidelines for hypertension treatment.
Arm Title
Control
Arm Type
No Intervention
Arm Description
The control group will receive usual care according to the National Board of Health and Welfare guidelines for hypertension treatment.
Intervention Type
Behavioral
Intervention Name(s)
SMS
Intervention Description
The experimental treatment will consist of health promoting text messages addressing metabolic risk factors associated with cardiovascular disorders in patients with hypertension. Participants will receive four semi-personalized messages per week in addition to their usual care. The text messages will be developed to support healthy life style changes i.e. regarding general cardiovascular health, tobacco use, physical activity and diet.
Primary Outcome Measure Information:
Title
Change in blood pressure
Description
Measured by automated devices (mmHg)
Time Frame
Six months
Secondary Outcome Measure Information:
Title
Changes in cholesterol
Description
Measured by blood test, total cholesterol (mmol/l)
Time Frame
six months
Title
Changes in high-density lipoprotein [HDL]
Description
Measured by blood test, high-density lipoprotein [HDL] (mmol/l)
Time Frame
six months
Title
Changes in low-density lipoprotein [LDL]
Description
Measured by blood test, low-density lipoprotein [LDL] (mmol/l)
Time Frame
six months
Title
Changes in tobacco use
Description
Self-reported
Time Frame
six months
Title
Changes in BMI
Description
Measured by research assistant at baseline and follow up (weight and hight will be combined to report BMI in kg/m2)
Time Frame
six months
Title
Changes in Blood glucose
Description
HbA1c
Time Frame
six months
Title
Changes in self-rated health
Description
five-graded Likert scale from excellent to poor. The question posed is; in general, would you say that you health is excellent, very good, good, fair, or poor?
Time Frame
six months
Title
Changes in self rated quality of life
Description
EQ5D-5L (EuroQol 5 dimentions).The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.
Time Frame
six months
Title
Changes in level of physical activity
Description
self-reported physical activity
Time Frame
six months
Title
Changes in alcohol use
Description
self-reported
Time Frame
six months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with hypertension (defined by the International classification of disease Manual ICD-10, diagnose code I10.9).
40 to 80 years of age
Patient must own a mobile phone compatible with SMS
Exclusion Criteria:
History of myocardial infarction, stroke, transient ischemic attack (TIA), claudicatio intermittens, abdominal aortic aneurysm, previous heart surgery i.e. PCI or bypass (reported by recruiting physician or by patient in the questionnaire)
Blood pressure at baseline visit ≥180/110 mmHg or systolic blood pressure <120 mmHg.
Serious illness, other than cardiovascular, with short life expectancy (<1 year)
Predicted inability to comply with the study protocol e.g. language difficulties, interpreter needs, serious cognitive impairment.
Facility Information:
Facility Name
Lomma vårdcentral
City
Lomma
State/Province
Skåne
ZIP/Postal Code
23434
Country
Sweden
Facility Name
Löddeköpinge vårdcentral
City
Löddeköpinge
State/Province
Skåne
ZIP/Postal Code
24630
Country
Sweden
Facility Name
Sorgenfri vårdcentral
City
Malmö
State/Province
Skåne
ZIP/Postal Code
214 33
Country
Sweden
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
27863813
Citation
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017 Jan 7;389(10064):37-55. doi: 10.1016/S0140-6736(16)31919-5. Epub 2016 Nov 16. Erratum In: Lancet. 2020 Sep 26;396(10255):886.
Results Reference
background
PubMed Identifier
24002282
Citation
Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S; PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182.
Results Reference
background
PubMed Identifier
15145106
Citation
Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol. 2004 May 19;43(10):1817-22. doi: 10.1016/j.jacc.2003.12.049.
Results Reference
background
PubMed Identifier
26654259
Citation
Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016 May;26(4):364-73. doi: 10.1016/j.tcm.2015.10.004. Epub 2015 Oct 31.
Results Reference
background
PubMed Identifier
25100267
Citation
Lin H, Wu X. Intervention strategies for improving patient adherence to follow-up in the era of mobile information technology: a systematic review and meta-analysis. PLoS One. 2014 Aug 6;9(8):e104266. doi: 10.1371/journal.pone.0104266. eCollection 2014.
Results Reference
background
PubMed Identifier
19382860
Citation
Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health. 2009 Apr;15(3):231-40. doi: 10.1089/tmj.2008.0099.
Results Reference
background
PubMed Identifier
26456490
Citation
Bengtsson U, Kjellgren K, Hallberg I, Lindwall M, Taft C. Improved Blood Pressure Control Using an Interactive Mobile Phone Support System. J Clin Hypertens (Greenwich). 2016 Feb;18(2):101-8. doi: 10.1111/jch.12682. Epub 2015 Oct 12.
Results Reference
background
PubMed Identifier
26393848
Citation
Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, Jan S, Graves N, de Keizer L, Barry T, Bompoint S, Stepien S, Whittaker R, Rodgers A, Thiagalingam A. Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial. JAMA. 2015 Sep 22-29;314(12):1255-63. doi: 10.1001/jama.2015.10945. Erratum In: JAMA. 2016 Mar 8;315(10):1057.
Results Reference
background
PubMed Identifier
24314119
Citation
Wolff M, Sundquist K, Larsson Lonn S, Midlov P. Impact of yoga on blood pressure and quality of life in patients with hypertension - a controlled trial in primary care, matched for systolic blood pressure. BMC Cardiovasc Disord. 2013 Dec 7;13:111. doi: 10.1186/1471-2261-13-111.
Results Reference
background
PubMed Identifier
11701584
Citation
Vickers AJ, Altman DG. Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ. 2001 Nov 10;323(7321):1123-4. doi: 10.1136/bmj.323.7321.1123. No abstract available.
Results Reference
background
Links:
URL
http://www.mrc.ac.uk/complexinterventionsguidance
Description
Council MR. Developing and evaluating complex interventions: new guidance 2008
Learn more about this trial
Text Message Intervention for Prevention of Cardiovascular Disease in Primary Care Patients With Hypertension
We'll reach out to this number within 24 hrs